Gene Therapy Market Size, Share, Trends, Growth Factors, and Regional Outlook To 2032
The Gene Therapy Market is projected to grow from USD 10.8 billion in 2024 to USD 43.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.87% during the forecast period (2024 - 2032).
Gene therapy, a ground-breaking
field in the realm of medicine, is rapidly transforming the landscape of
healthcare. It involves the introduction, alteration, or replacement of genetic
material within an individual's cells to treat or prevent diseases. This
innovative approach holds immense promise, offering potential cures for
previously incurable genetic disorders and chronic conditions.
The gene therapy market is
witnessing unprecedented growth, fueled by advancements in molecular biology,
genetic engineering, and biotechnology. One of the key driving forces behind
this growth is the convergence of gene therapy with cell therapy, creating a
powerful synergy that enhances treatment efficacy across a spectrum of
diseases.
Cell therapy,
a pivotal component of the gene therapy landscape, involves the transplantation
of living cells into a patient's body for therapeutic purposes. Stem cells, in
particular, play a crucial role in regenerative medicine, offering the
potential to repair damaged tissues and organs. The integration of cell therapy
with gene therapy amplifies the therapeutic impact by addressing both genetic
and cellular aspects of diseases. This combined approach holds tremendous
potential for treating conditions such as cancer, neurodegenerative disorders,
and autoimmune diseases.
Major Key
Players:
Some of the Gene Therapy Companies are Amgen,
Inc. (US), Novartis AG (Switzerland), Spark Therapeutics, Inc. (US), Gilead
Sciences, Inc. (US), uniQure N.V. (Netherlands), Orchard Therapeutics plc (UK),
Celgene Corporation (US), Bristol-Myers Squibb Company (US), Thermo Fisher
Scientific Inc. (US), CEVEC (Germany), and Lonza (Switzerland).
Segment Analysis
The global gene therapy
market has been segmented based on product, indication, and end user.
The market, based on
product, has been divided into kymriah, luxturna, yescarta, zolgensma,
strimvelis, zynteglo, imlygic, and others.
The global gene therapy
market has on the basis of indication is segmented, into oncology, genetic
diseases/ disorders, and others. The oncology segment is expected to hold
the largest market share and to be the fastest-growing segment due to high
prevalence of cancer and robust pipeline for cancer gene therapy.
The end-user segments
of the market are hospitals & clinics, specialty treatment centers, and
others. The hospitals & clinics segment is expected to hold the
largest market share due to increasing number of hospitals. Also, hospitals are
generally the first treatment choice for diseases.
Regional
Analysis
The global gene therapy
market is studied across four major regions: Asia-Pacific, Europe, the
Americas, the Middle East, and Africa.
According to the MRFR
reports, the American regional gene therapy market is likely to dominate
globally over the review timeframe. The regional market's growth is driven by
the rising per capita medical care consumption and the expanding pervasiveness
of quality treatment. The regional market is further divided into Latin America
and North America.
The European regional market
will likely register substantial growth over the review timeframe. The region
is further divided into Eastern Europe and Western Europe. The well-established
medical infrastructure is driving the regional market's growth.
The Asia-Pacific region is
projected to grow at the highest pace over the coming years. The bringing
issues are driving the regional market's growth to light about the treatment
strategies and growing number of patients.
Given the lack of skilled
professionals and poor health infrastructure, the gene therapy market for the
Middle East & African region is likely to record the CAGR over the
assessment timeframe.
Browse Related
Reports:
Central Pontine Myelinolysis Market
Americas Blood Glucose Monitoring Market
For More
Information, Please Visit @ Market Research Future
Comments
Post a Comment